NFATc1: Functions in osteoclasts

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 5, 2010, Pages 576-579

  Zhao, Qingxiao ^a   Wang, Xi ^b   Liu, Yuehua ^a   He, Aimin ^a   Jia, Ruokun ^a  

^a NORTHEAST ELECTRIC POWER UNIVERSITY   (China)

^b General Hospital of CNPC in Jilin   (China)

Author keywords

Autoamplification; Ca2+; NFATc1; Osteoclasts; RANKL

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC1; UNCLASSIFIED DRUG;

ACIDIFICATION; BONE MATRIX; CELL ACTIVATION; CELL ADHESION; CELL DIFFERENTIATION; CELL FUSION; CELL MIGRATION; GENE CONTROL; HEART VALVE; LYMPH VESSEL ENDOTHELIUM; LYMPHOCYTE DIFFERENTIATION; MORPHOGENESIS; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; PROTEIN FUNCTION; PROTEIN STRUCTURE; SHORT SURVEY; T LYMPHOCYTE; UPREGULATION;

ANIMALS; BONE RESORPTION; CALCIUM SIGNALING; CELL ADHESION; CELL DIFFERENTIATION; CELL FUSION; CELL MOVEMENT; HUMANS; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; UP-REGULATION;

EID: 77649191328     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.12.018     Document Type: Short Survey

References (30)

1. Asagiri M., Sato K., Usami T., Ochi S., Nishina H., Yoshida H., et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med 202 (2005) 1261-1269
2. Bu S., Lerner M., Stoecker B., Boldrin E., Brackett D., Lucas E., et al. Dried plum polyphenols inhibit osteoclastogenesis by downregulating NFATc1 and inflammatory mediators. Calcif Tissue Int 82 (2008) 475-488
3. Combs M., and Yutzey K. Vascular endothelial growth factor A and RANKL regulation of NFATc1 in heart valve development. Circ Res 105 (2009) 565-574
4. Crotti T.N., Sharma S.M., Fleming J.D., Flannery M.R., Ostrowski M.C., Goldring S.R., et al. PU.1 and NFATc1 mediate osteoclastic induction of the mouse beta3 integrin promoter. J Cell Physiol 215 (2008) 636-644
5. Evans K.E., and Fox S.W. Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus. BMC Cell Biol 8 (2007) 4
6. Feng H., Cheng T., Steer J.H., Joyce D.A., Pavlos N.J., Leong C., et al. Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis. J Biol Chem 284 (2009) 14667-14676
7. Ha J., Choi H.S., Lee Y., Lee Z.H., and Kim H.H. Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos. Int Immunopharmacol 9 (2009) 774-780
8. Huang H., Chang E.J., Ryu J., Lee Z.H., Lee Y., and Kim H.H. Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Biochem Biophys Res Commun 351 (2006) 99-105
9. Ikeda F., Nishimura R., Matsubara T., Tanaka S., Inoue J., Reddy S.V., et al. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest 114 (2004) 475-484
10. Kim K., Lee S., Ha Kim J., Choi Y., and Kim N. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol 22 (2008) 176-185
11. Koga T., Inui M., Inoue K., Kim S., Suematsu A., Kobayashi E., et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428 (2004) 758-763
12. Koide M., Kinugawa S., Ninomiya T., Mizoguchi T., Yamashita T., Maeda K., et al. Diphenylhydantoin inhibits osteoclast differentiation and function through suppression of NFATc1 signaling. J Bone Miner Res 24 (2009) 1469-1480
13. 2+ oscillation-independent NFATc1 activation during osteoclastogenesis. Proc Natl Acad Sci USA 105 (2008) 8643-8648
14. Liu F., Zhu Z., Mao Y., Liu M., Tang T., and Qiu S. Inhibition of titanium particle-induced osteoclastogenesis through inactivation of NFATc1 by VIVIT peptide. Biomaterials 30 (2009) 1756-1762
15. Mao D., Epple H., Uthgenannt B., Novack D.V., and Faccio R. PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. J Clin Invest 116 (2006) 2869-2879
16. Matsumoto M., Kogawa M., Wada S., Takayanagi H., Tsujimoto M., Katayama S., et al. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J Biol Chem 279 (2004) 45969-45979
17. Mocsai A., Humphrey M.B., Van Ziffle J.A., Hu Y., Burghardt A., Spusta S.C., et al. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci USA 101 (2004) 6158-6163
18. Mutungi G. The expression of NFATc1 in adult rat skeletal muscle fibres. Exp Physiol 93 (2008) 399-406
19. Penolazzi L., Zennaro M., Lambertini E., Tavanti E., Torreggiani E., Gambari R., et al. Induction of estrogen receptor alpha expression with decoy oligonucleotide targeted to NFATc1 binding sites in osteoblasts. Mol Pharmacol 71 (2007) 1457-1462
20. Ranger A.M., Grusby M.J., Hodge M.R., Gravallese E.M., De La Brousse F.C., Hoey T., et al. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392 (1998) 186-190
21. Rao A., Luo C., and Hogan P.G. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15 (1997) 707-747
22. Sakai S., Takaishi H., Matsuzaki K., Kaneko H., Furukawa M., Miyauchi Y., et al. 1-Alpha,25-dihydroxy vitamin D(3) inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression. J Bone Miner Metab 27 (2009) 643-652
23. Serfling E., Chuvpilo S., Liu J., Hofer T., and Palmetshofer A. NFATc1 autoregulation: a crucial step for cell-fate determination. Trends Immunol 27 (2006) 461-469
24. Song I., Kim J.H., Kim K., Jin H.M., Youn B.U., and Kim N. Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation. FEBS Lett 583 (2009) 2435-2440
25. Takayanagi H. The role of NFAT in osteoclast formation. Ann N Y Acad Sci 1116 (2007) 227-237
26. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3 (2002) 889-901
27. 2+ oscillation. EMBO J 22 (2003) 3825-3832
28. Winslow M.M., Pan M., Starbuck M., Gallo E.M., Deng L., Karsenty G., et al. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev Cell 10 (2006) 771-782
29. Yehya A., Souki R., Bitar F., and Nemer G. Differential duplication of an intronic region in the NFATC1 gene in patients with congenital heart disease. Genome 49 (2006) 1092-1098
30. Zhou P., Sun L.J., Dotsch V., Wagner G., and Verdine G.L. Solution structure of the core NFATC1/DNA complex. Cell 92 (1998) 687-696